{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:34:14Z","timestamp":1786480454823,"version":"build-2736575974"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004368","name":"Colgate Palmolive Co","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","award":["1S91925N"],"award-info":[{"award-number":["1S91925N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.lfs.2026.124587","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:27:35Z","timestamp":1783924055000},"page":"124587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Human stem cell-derived hepatic cells recapitulate polygenic risk in MASLD development and highlight CD36 as a key mediator"],"prefix":"10.1016","volume":"402","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7478-3405","authenticated-orcid":false,"given":"Alexandra","family":"Gatzios","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6780-9184","authenticated-orcid":false,"given":"Marth","family":"Stinckens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1275-9498","authenticated-orcid":false,"given":"Anouk","family":"Verhoeven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1101-1739","authenticated-orcid":false,"given":"Matthias","family":"Rombaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinja","family":"De Win","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Heymans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Loosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5672-0048","authenticated-orcid":false,"given":"Freddy","family":"Van Goethem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4078-4896","authenticated-orcid":false,"given":"Joery","family":"De Kock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2927-6791","authenticated-orcid":false,"given":"Robim M.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8399-5872","authenticated-orcid":false,"given":"Joost","family":"Boeckmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6685-7299","authenticated-orcid":false,"given":"Tamara","family":"Vanhaecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl","key":"10.1016\/j.lfs.2026.124587_bb0005","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Younossi","year":"2024","journal-title":"Clin. Mol. Hepatol."},{"issue":"2","key":"10.1016\/j.lfs.2026.124587_bb0010","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S2213-8587(24)00318-8","article-title":"Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment","volume":"13","author":"Stefan","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"1","key":"10.1016\/j.lfs.2026.124587_bb0015","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000016","article-title":"Novel metabolic phenotypes for extrahepatic complication of nonalcoholic fatty liver disease","volume":"7","author":"Yi","year":"2023","journal-title":"Hepatol. Commun."},{"issue":"4","key":"10.1016\/j.lfs.2026.124587_bb0020","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/HC9.0000000000000112","article-title":"Clustering NAFLD: phenotypes of nonalcoholic fatty liver disease and their differing trajectories","volume":"7","author":"Kantartzis","year":"2023","journal-title":"Hepatol. Commun."},{"issue":"1","key":"10.1016\/j.lfs.2026.124587_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10010161","article-title":"From NAFLD to MAFLD: aligning translational in vitro research to clinical insights","volume":"10","author":"Gatzios","year":"2022","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.lfs.2026.124587_bb0030","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/joim.12719","article-title":"Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver","volume":"283","author":"Dongiovanni","year":"2018","journal-title":"J. Intern. Med."},{"issue":"4","key":"10.1016\/j.lfs.2026.124587_bb0035","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jhep.2020.11.024","article-title":"Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores","volume":"74","author":"Bianco","year":"2021","journal-title":"J. Hepatol."},{"issue":"12","key":"10.1016\/j.lfs.2026.124587_bb0040","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1038\/s41591-024-03283-1","article-title":"Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease","volume":"30","author":"Raverdy","year":"2024","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.lfs.2026.124587_bb0045","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.lfs.2026.124587_bb0050","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/liv.15533","article-title":"PNPLA3 I148M and response to treatment for hepatic steatosis: a systematic review","volume":"43","author":"Boeckmans","year":"2023","journal-title":"Liver Int."},{"issue":"D1","key":"10.1016\/j.lfs.2026.124587_bb0055","doi-asserted-by":"crossref","first-page":"D891","DOI":"10.1093\/nar\/gkad1049","article-title":"Ensembl 2024","volume":"52","author":"Harrison","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/j.lfs.2026.124587_bb0060","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1194\/jlr.M500290-JLR200","article-title":"Expression, regulation, and triglyceride hydrolase activity of Adiponutrin family members","volume":"46","author":"Lake","year":"2005","journal-title":"J. Lipid Res."},{"issue":"2","key":"10.1016\/j.lfs.2026.124587_bb0065","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1194\/jlr.M011205","article-title":"Pnpla3\/adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome","volume":"52","author":"Basantani","year":"2011","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.lfs.2026.124587_bb0070","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2010.10.024","article-title":"Distinct regulation of adiponutrin\/PNPLA3 gene expression by the transcription factors ChREBP and SREBP1c in mouse and human hepatocytes","volume":"55","author":"Dubuquoy","year":"2011","journal-title":"J. Hepatol."},{"issue":"17","key":"10.1016\/j.lfs.2026.124587_bb0075","doi-asserted-by":"crossref","first-page":"7892","DOI":"10.1073\/pnas.1003585107","article-title":"A feed-forward loop amplifies nutritional regulation of PNPLA3","volume":"107","author":"Huang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.lfs.2026.124587_bb0080","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10565-020-09544-2","article-title":"Human hepatic in vitro models reveal distinct anti-NASH potencies of PPAR agonists","volume":"37","author":"Boeckmans","year":"2021","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.lfs.2026.124587_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175989","article-title":"Human skin stem cell-derived hepatic cells as in vitro drug discovery model for insulin-driven de novo lipogenesis","volume":"957","author":"Buyl","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2026.124587_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2025.154263","article-title":"A mechanistically-anchored and human stem cell-based in vitro test battery for assessing liver steatogenic potential of chemicals","volume":"518","author":"Verhoeven","year":"2025","journal-title":"Toxicology"},{"issue":"6","key":"10.1016\/j.lfs.2026.124587_bb0095","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1038\/nprot.2006.422","article-title":"Isolation of skin-derived precursors (SKPs) and differentiation and enrichment of their Schwann cell progeny","volume":"1","author":"Biernaskie","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.lfs.2026.124587_bb0100","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.tiv.2011.03.013","article-title":"Evaluation of the multipotent character of human foreskin-derived precursor cells","volume":"25","author":"De Kock","year":"2011","journal-title":"Toxicol. in Vitro"},{"issue":"1","key":"10.1016\/j.lfs.2026.124587_bb0105","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1089\/scd.2013.0157","article-title":"Human skin-derived stem cells as a novel cell source for in vitro hepatotoxicity screening of pharmaceuticals","volume":"23","author":"Rodrigues","year":"2014","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.lfs.2026.124587_bb0110","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13059-019-1671-x","article-title":"BRB-seq: ultra-affordable high-throughput transcriptomics enabled by bulk RNA barcoding and sequencing","volume":"20","author":"Alpern","year":"2019","journal-title":"Genome Biol."},{"key":"10.1016\/j.lfs.2026.124587_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.mex.2020.101068","article-title":"Flow cytometric quantification of neutral lipids in a human skin stem cell-derived model of NASH","volume":"7","author":"Boeckmans","year":"2020","journal-title":"MethodsX"},{"issue":"7","key":"10.1016\/j.lfs.2026.124587_bb0120","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.lfs.2026.124587_bb0125","series-title":"Designing Clinical Research","first-page":"55","article-title":"Estimating sample size and power: applications and examples","author":"Hulley","year":"2013"},{"key":"10.1016\/j.lfs.2026.124587_bb0130","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.lfs.2026.124587_bb0135","series-title":"Ggplot2: Elegant Graphics for Data Analysis; Use R!","author":"Wickham","year":"2016"},{"key":"10.1016\/j.lfs.2026.124587_bb0140","series-title":"EnhancedVolcano: Publication-Ready Volcano Plots With Enhanced Colouring and Labeling","author":"Blighe","year":"2025"},{"key":"10.1016\/j.lfs.2026.124587_bb0145","series-title":"pheatmap: Pretty Heatmaps","author":"Kolde","year":"2025"},{"issue":"3","key":"10.1016\/j.lfs.2026.124587_bb0150","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.cgh.2021.05.056","article-title":"A polygenic risk score to refine risk stratification and prediction for severe liver disease by clinical fibrosis scores","volume":"20","author":"De Vincentis","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.lfs.2026.124587_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1524","article-title":"Estrogen\u2013ER-\u03b1 axis induces PNPLA3 p.I148M protein variant to promote steatotic liver disease susceptibility in women","volume":"14","author":"Cherubini","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.lfs.2026.124587_bb0160","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jhep.2022.08.022","article-title":"IL-6\/STAT3 axis dictates the PNPLA3-mediated susceptibility to non-alcoholic fatty liver disease","volume":"78","author":"Park","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2026.124587_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101428","article-title":"CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing","volume":"57","author":"Zeng","year":"2022","journal-title":"Mol. Metab."},{"issue":"3","key":"10.1016\/j.lfs.2026.124587_bb0170","article-title":"Reviewing MAESTRO-NASH and the implications for hepatology and health systems in implementation\/accessibility of Resmetirom","volume":"2","author":"Brennan","year":"2025","journal-title":"Npj Gut Liver"},{"issue":"3","key":"10.1016\/j.lfs.2026.124587_bb0175","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1053\/j.gastro.2023.11.018","article-title":"PNPLA3 risk allele association with ALT response to semaglutide treatment","volume":"166","author":"Urias","year":"2024","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.lfs.2026.124587_bb0180","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/jgh.12656","article-title":"PNPLA3 gene polymorphism and response to lifestyle modification in patients with nonalcoholic fatty liver disease","volume":"30","author":"Shen","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.lfs.2026.124587_bb0185","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3945\/ajcn.111.012369","article-title":"Genetic variation in PNPLA3 (adiponutrin) confers sensitivity to weight loss - induced decrease in liver fat in humans","volume":"94","author":"Sevastianova","year":"2011","journal-title":"Am. J. Clin. Nutr."},{"issue":"4","key":"10.1016\/j.lfs.2026.124587_bb0190","doi-asserted-by":"crossref","DOI":"10.1111\/liv.16186","article-title":"Targeting PNPLA3 to treat MASH and MASH related fibrosis and cirrhosis","volume":"45","author":"Lind\u00e9n","year":"2024","journal-title":"Liver Int."},{"issue":"9","key":"10.1016\/j.lfs.2026.124587_bb0195","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1152\/ajpendo.00125.2011","article-title":"PNPLA3 is regulated by glucose in human hepatocytes, and its I148M mutant slows down triglyceride hydrolysis","volume":"302","author":"Perttil\u00e4","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.lfs.2026.124587_bb0200","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/liv.14402","article-title":"Metabolic regulation of hepatic PNPLA3 expression and severity of liver fibrosis in patients with NASH","volume":"40","author":"Bruschi","year":"2020","journal-title":"Liver Int."},{"issue":"4","key":"10.1016\/j.lfs.2026.124587_bb0205","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jhep.2024.09.043","article-title":"PNPLA3 rs738409, environmental factors and liver-related mortality in the US population","volume":"82","author":"Vilar-Gomez","year":"2025","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.lfs.2026.124587_bb0210","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/j.1572-0241.2007.01774.x","article-title":"Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis","volume":"103","author":"Wieckowska","year":"2008","journal-title":"Am. J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.lfs.2026.124587_bb0215","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/hep.29273","article-title":"The PNPLA3 variant associated with fatty liver disease (I148M) accumulates on lipid droplets by evading ubiquitylation","volume":"66","author":"BasuRay","year":"2017","journal-title":"Hepatology"},{"issue":"19","key":"10.1016\/j.lfs.2026.124587_bb0220","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1093\/bioinformatics\/btq466","article-title":"ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments","volume":"26","author":"Lachmann","year":"2010","journal-title":"Bioinformatics"},{"issue":"D1","key":"10.1016\/j.lfs.2026.124587_bb0225","doi-asserted-by":"crossref","first-page":"D1016","DOI":"10.1093\/nar\/gkae1080","article-title":"Harmonizome 3.0: integrated knowledge about genes and proteins from diverse multi-omics resources","volume":"53","author":"Diamant","year":"2025","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"10.1016\/j.lfs.2026.124587_bb0230","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1136\/gut.2010.222844","article-title":"Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C","volume":"60","author":"Miquilena-Colina","year":"2011","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.lfs.2026.124587_bb0235","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3350\/cmh.2013.19.3.210","article-title":"Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis","volume":"19","author":"Koo","year":"2013","journal-title":"Clin. Mol. Hepatol."},{"issue":"6","key":"10.1016\/j.lfs.2026.124587_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107351","article-title":"STAT3 activation of SCAP-SREBP-1 signaling upregulates fatty acid synthesis to promote tumor growth","volume":"300","author":"Fan","year":"2024","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.lfs.2026.124587_bb0245","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1152\/ajpgi.00074.2008","article-title":"Gene expression in human NAFLD","volume":"294","author":"Greco","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.lfs.2026.124587_bb0250","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11010-005-9031-4","article-title":"Physiological and pathological roles of a multi-ligand receptor CD36 in atherogenesis; insights from CD36-deficient patients","volume":"299","author":"Yamashita","year":"2007","journal-title":"Mol. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.lfs.2026.124587_bb0255","doi-asserted-by":"crossref","first-page":"E187","DOI":"10.1152\/ajpendo.00161.2022","article-title":"Investigating dual inhibition of ACC and CD36 for the treatment of nonalcoholic fatty liver disease in mice","volume":"324","author":"Devereux","year":"2023","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.lfs.2026.124587_bb0260","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1210\/en.2015-1866","article-title":"Hepatocyte-specific disruption of CD36 attenuates fatty liver and improves insulin sensitivity in HFD-fed mice","volume":"157","author":"Wilson","year":"2016","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.lfs.2026.124587_bb0265","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jhep.2024.01.032","article-title":"Exploring the impact of the PNPLA3 I148M variant on primary human hepatic stellate cells using 3D extracellular matrix models","volume":"80","author":"Caon","year":"2024","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.lfs.2026.124587_bb0270","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.1038\/s41467-024-49224-x","article-title":"PNPLA3 is a triglyceride lipase that mobilizes polyunsaturated fatty acids to facilitate hepatic secretion of large-sized very low-density lipoprotein","volume":"15","author":"Johnson","year":"2024","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.lfs.2026.124587_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103071","article-title":"Inflammatory stress increases hepatic CD36 translational efficiency via activation of the mTOR Signalling pathway","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.lfs.2026.124587_bb0280","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1038\/s41591-023-02553-8","article-title":"Interaction between estrogen receptor-\u03b1 and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women","volume":"29","author":"Cherubini","year":"2023","journal-title":"Nat. Med."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320526003966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320526003966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:23:37Z","timestamp":1786479817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320526003966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":56,"alternative-id":["S0024320526003966"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2026.124587","relation":{"is-supplemented-by":[{"id-type":"uri","id":"https:\/\/www.ebi.ac.uk\/biostudies\/ArrayExpress\/studies\/E-MTAB-15891#","asserted-by":"subject"}]},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human stem cell-derived hepatic cells recapitulate polygenic risk in MASLD development and highlight CD36 as a key mediator","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2026.124587","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"124587"}}